DT BioPharma Consulting

The Gold Standard in Bio-Pharma Strategy.

At DT BioPharma Consulting, we work to transform complex data into powerful narratives.

We provide tailored publication services designed to meet your most ambitious communication and training objectives.

With a foundation of deep industry expertise, we deliver the insights and precision needed to achieve both your immediate milestones and your long-term strategic vision.

About Us

Global Expertise. Ethical Innovation.

Our Mission

To increase scientific credibility and advance communication that empowers both the medical community and the patients it serves.

What we do

We assist global pharma, academia, and biotech organizations in navigating the evolving landscape of medical affairs and evidence generation.

Our Core Capabilities

  • Strategic Publication Planning: Seamless management grounded in GPP and ICMJE standards.

  • Omnichannel Communication: Integrated congress planning and digital engagement.

  • Patient Advocacy: Making scientific evidence accessible, relevant, and actionable for those who need it most.

  • Future-Ready Solutions: Guiding teams through the ethical integration of AI and digital tools.

Services

Omnichannel Communication & Congress Support

We deliver integrated strategies for congress planning and digital engagement. We ensure your data reaches the right audience through a seamless, multi-channel approach.

Patient Advocacy & Engagement

We transform complex scientific evidence into accessible, relevant, and actionable insights. Our services bridge the gap between clinical data and the patients and advocates who need it most.

Strategic Publication Planning & Compliance

We provide end-to-end publication management grounded in GPP and ICMJE standards. Our team ensures your scientific evidence is navigated through the evolving landscape of medical affairs with precision and regulatory integrity.

Digital Transformation & AI Consulting

We offer future-ready solutions to help your team ethically integrate AI and digital tools into your medical communication workflows.

Selected Publications

Bharadia, Geissler, Robson, Lastikova, Porter, Richmond, Johnson, Roch, Toroser (2025) Seven actions toward advancing patient authorship and collaboration in peer-reviewed publications. Patient. 18(5): 403-414

Toroser, deTora, Cairns, Juneja, Georgieva, Weigel, Pepitone (2015) The Sunshine Act and medical publications: Guidance from professional medical associations. Postgrad Med. 127(7) 752-7 

deTora, Toroser, Sykes, Vanderlinden, Plunkett, Lane, Hanekamp, Dormer, DiBiasi, Bridges, Baltzer, Citrome (2022) Good Publication Practice (GPP) Guidelines for company-sponsored biomedical research: 2022 Update.Ann Intern Med. 175(9): 1298-1304

Puthige, Toroser, Mehra, Mukundan, Kapadia, (2025) GPP 2022: perspectives, sentiments, and feedback from the publications community. Curr Med Res Opin, 41(5): 879-885

Toroser, Yarian, Orr, Sohal (2006) Gamma-glutamylcysteine ligase regulation. Biochim Biophys Acta, 1760(2): 233-44 

Toroser, Robinson, Gegner, Smith, Nilsen, Hyatt, Johnson, Hassan, Gatchalian (2016) Systematic review of reports describing potential impact of the Sunshine Act on peer-reviewed medical publications. Curr Med Res Opin, 32(3):547-53

Toroser, Carlson, Robinson, Gegner, Girard, Smette, Nilsen, O’Kelly. (2017) Factors impacting time to acceptance and publication for peer-reviewed publications. Curr Med Res Opin, 33(7): 1183-1189

Toroser, Huber (1998) 3-hydroxy-3-methylglutarylCoA reductase kinase regulation. Arch Biochem Biophys 355(2): 291-300

Useful Links

  • GPP 2022: deTora, Toroser, Sykes et al.,…Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update :GPP GUIDELINES

  • ICMJE: International Committee of Medical Journal Editors (Recommendations): www.icmje.org

  • MPIP: Medical Publishing Insights & Practices:www.mpip-initiative.org

Reporting Guidelines

Professional Organizations

  • International Society for Medical Publication Professionals (ISMPP): Link: ISMPP

  • Asian Council of Science Editors (ACSE): Link: ACSE

  • Q1 Productions: Link: Q1 Conferences

  • STARTUP BOSTON: Link: Events

  • CONSORT: Consolidated Standards of Reporting Trials. Link: CONSORT

  • PRISMA: Preferred Reporting Items for Systematic Reviews and MetaAnalyses. Link:PRISMA

  • CHEERS: Consolidated Health Economic Evaluation Reporting Standards. Link:CHEERS

  • STROBE: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)Statement: guidelines for reporting observational studies. Link:STROBE

  • SPIRIT: Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration. Link: SPIRIT

  • SQUIRE: SQUIRE 2.0 (Standards for Quality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. Link:SQUIRE

Contact Us

Email: CONTACT@dtbiopharma.com

Inquiry Form